These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24392350)

  • 41. Loading of the antigen-presenting protein CD1d with synthetic glycolipids.
    Wallner FK; Chen L; Moliner A; Jondal M; Elofsson M
    Chembiochem; 2004 Apr; 5(4):437-44. PubMed ID: 15185366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sialidase significance for cancer progression.
    Miyagi T; Takahashi K; Hata K; Shiozaki K; Yamaguchi K
    Glycoconj J; 2012 Dec; 29(8-9):567-77. PubMed ID: 22644327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutral glycolipids and gangliosides of concanavalin A-selected SV3T3 revertant cells and of normal and SV40-transformed Balb/c 3T3 cells.
    Mugnai G; Coppini R; Tombaccini D; Fallani A; Ruggieri S
    Biochem J; 1981 Mar; 193(3):1025-8. PubMed ID: 6272715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
    Padler-Karavani V
    Cancer Lett; 2014 Sep; 352(1):102-12. PubMed ID: 24141190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies against tumor cell glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity.
    Ragupathi G; Liu NX; Musselli C; Powell S; Lloyd K; Livingston PO
    J Immunol; 2005 May; 174(9):5706-12. PubMed ID: 15843572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
    Groux-Degroote S; Delannoy P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Regulation of the superprecipitation of an actomyosin-like protein from the brain by glycolipids].
    Glebov RN; Kryzhanovskiĭ GN; Shvets VI; Sandalov IuG
    Biokhimiia; 1982 May; 47(5):791-6. PubMed ID: 6980021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.
    Goodfellow JA; Willison HJ
    Curr Opin Neurol; 2016 Oct; 29(5):572-80. PubMed ID: 27427992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination with Tumor-Ganglioside Glycomimetics Activates a Selective Immunity that Affords Cancer Therapy.
    Tong W; Maira M; Roychoudhury R; Galan A; Brahimi F; Gilbert M; Cunningham AM; Josephy S; Pirvulescu I; Moffett S; Saragovi HU
    Cell Chem Biol; 2019 Jul; 26(7):1013-1026.e4. PubMed ID: 31105061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surface markers in stem cells and cancer from the perspective of glycomic analysis.
    Cho HC; Liao CH; Yu AL; Yu J
    Int J Biol Markers; 2012 Dec; 27(4):e344-52. PubMed ID: 23250773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative N-glycoproteomics of milk fat globule membrane in human colostrum and mature milk reveals changes in protein glycosylation during lactation.
    Cao X; Kang S; Yang M; Li W; Wu S; Han H; Meng L; Wu R; Yue X
    Food Funct; 2018 Feb; 9(2):1163-1172. PubMed ID: 29363704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gangliosides and glycolipids in neurodegenerative disorders.
    Schneider JS
    Adv Neurobiol; 2014; 9():449-61. PubMed ID: 25151391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.
    Boccuto L; Aoki K; Flanagan-Steet H; Chen CF; Fan X; Bartel F; Petukh M; Pittman A; Saul R; Chaubey A; Alexov E; Tiemeyer M; Steet R; Schwartz CE
    Hum Mol Genet; 2014 Jan; 23(2):418-33. PubMed ID: 24026681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [GLYCOLIPIDS].
    POLONOVSKI J
    Bull Soc Chim Biol (Paris); 1964; 46():833-57. PubMed ID: 14226068
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.
    Rinaldi S; Brennan KM; Kalna G; Walgaard C; van Doorn P; Jacobs BC; Yu RK; Mansson JE; Goodyear CS; Willison HJ
    PLoS One; 2013; 8(12):e82337. PubMed ID: 24358172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfoglucuronyl glycolipids bind laminin.
    Mohan PS; Chou DK; Jungalwala FB
    J Neurochem; 1990 Jun; 54(6):2024-31. PubMed ID: 2338555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fukutin protein family--predicted enzymes modifying cell-surface molecules.
    Aravind L; Koonin EV
    Curr Biol; 1999 Nov; 9(22):R836-7. PubMed ID: 10574772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.